Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vaginal Diseases | 2 | 2018 | 102 | 0.720 |
Why?
|
| Brain Neoplasms | 7 | 2020 | 8863 | 0.690 |
Why?
|
| Melanoma | 5 | 2020 | 5510 | 0.640 |
Why?
|
| Immunotherapy | 4 | 2019 | 4445 | 0.530 |
Why?
|
| Radiosurgery | 5 | 2019 | 1329 | 0.500 |
Why?
|
| Radiation Injuries | 2 | 2019 | 1180 | 0.460 |
Why?
|
| Brachytherapy | 2 | 2018 | 1248 | 0.440 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2017 | 1770 | 0.420 |
Why?
|
| Hysterectomy | 1 | 2017 | 927 | 0.400 |
Why?
|
| Endometrial Neoplasms | 2 | 2018 | 1353 | 0.400 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 4 | 2022 | 5221 | 0.360 |
Why?
|
| Gastrointestinal Diseases | 1 | 2017 | 1170 | 0.340 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2016 | 1821 | 0.330 |
Why?
|
| Patient Care Team | 1 | 2019 | 2531 | 0.310 |
Why?
|
| Medical Oncology | 1 | 2017 | 2265 | 0.260 |
Why?
|
| Constriction, Pathologic | 2 | 2018 | 1107 | 0.240 |
Why?
|
| Lung Neoplasms | 4 | 2022 | 13102 | 0.240 |
Why?
|
| Chordoma | 1 | 2023 | 359 | 0.180 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 6364 | 0.180 |
Why?
|
| Treatment Outcome | 5 | 2020 | 63114 | 0.160 |
Why?
|
| Gravidity | 1 | 2017 | 51 | 0.160 |
Why?
|
| Salpingectomy | 1 | 2017 | 53 | 0.150 |
Why?
|
| Dilatation | 1 | 2018 | 291 | 0.150 |
Why?
|
| Vagina | 2 | 2018 | 825 | 0.130 |
Why?
|
| Ovariectomy | 1 | 2017 | 661 | 0.130 |
Why?
|
| Tumor Burden | 1 | 2019 | 1915 | 0.110 |
Why?
|
| Disease Progression | 2 | 2020 | 13284 | 0.110 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2015 | 358 | 0.110 |
Why?
|
| Laser Therapy | 1 | 2019 | 1072 | 0.110 |
Why?
|
| Neoplasm Staging | 2 | 2017 | 11031 | 0.100 |
Why?
|
| Lymph Node Excision | 1 | 2017 | 1261 | 0.100 |
Why?
|
| Circadian Clocks | 1 | 2012 | 171 | 0.090 |
Why?
|
| Benzamides | 1 | 2015 | 1379 | 0.090 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2019 | 2043 | 0.080 |
Why?
|
| Combined Modality Therapy | 2 | 2019 | 8642 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2020 | 10252 | 0.070 |
Why?
|
| Alternative Splicing | 1 | 2012 | 1117 | 0.070 |
Why?
|
| Middle Aged | 7 | 2020 | 213383 | 0.070 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 12354 | 0.070 |
Why?
|
| DNA Repair | 1 | 2015 | 2046 | 0.070 |
Why?
|
| Survival Rate | 2 | 2019 | 12788 | 0.070 |
Why?
|
| Sulfonamides | 1 | 2015 | 1938 | 0.070 |
Why?
|
| Aged, 80 and over | 4 | 2019 | 57776 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2020 | 53288 | 0.070 |
Why?
|
| Aged | 6 | 2020 | 163280 | 0.060 |
Why?
|
| Drosophila melanogaster | 1 | 2012 | 1708 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 5535 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2017 | 7729 | 0.050 |
Why?
|
| Humans | 13 | 2023 | 744343 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 9239 | 0.050 |
Why?
|
| Female | 7 | 2020 | 380194 | 0.050 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 39050 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2017 | 12720 | 0.040 |
Why?
|
| Prognosis | 2 | 2019 | 29063 | 0.040 |
Why?
|
| Retrospective Studies | 5 | 2022 | 77449 | 0.040 |
Why?
|
| Muscles | 1 | 2023 | 1614 | 0.040 |
Why?
|
| Male | 5 | 2020 | 350118 | 0.040 |
Why?
|
| Adult | 5 | 2019 | 214055 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 9438 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 13695 | 0.030 |
Why?
|
| Intercalating Agents | 1 | 2015 | 34 | 0.030 |
Why?
|
| Circular Dichroism | 1 | 2015 | 354 | 0.030 |
Why?
|
| Etoposide | 1 | 2015 | 641 | 0.030 |
Why?
|
| Algorithms | 2 | 2023 | 13881 | 0.030 |
Why?
|
| Radiotherapy Dosage | 1 | 2018 | 2879 | 0.030 |
Why?
|
| Photoperiod | 1 | 2012 | 136 | 0.020 |
Why?
|
| RNA Splice Sites | 1 | 2012 | 209 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2015 | 1792 | 0.020 |
Why?
|
| RNA Editing | 1 | 2012 | 148 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2015 | 1899 | 0.020 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2015 | 594 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 35421 | 0.020 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 720 | 0.020 |
Why?
|
| Osteosarcoma | 1 | 2015 | 881 | 0.020 |
Why?
|
| Molecular Sequence Annotation | 1 | 2012 | 528 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2015 | 944 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 2214 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2015 | 3689 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2012 | 453 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2018 | 2684 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2012 | 2256 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 3557 | 0.020 |
Why?
|
| Neoplasms | 1 | 2015 | 21683 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2023 | 8949 | 0.020 |
Why?
|
| Exons | 1 | 2012 | 2437 | 0.020 |
Why?
|
| Brain | 1 | 2012 | 26385 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2012 | 2012 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 2529 | 0.010 |
Why?
|
| Base Sequence | 1 | 2012 | 12797 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 2012 | 2624 | 0.010 |
Why?
|
| Glioma | 1 | 2015 | 3401 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2023 | 20129 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 16689 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 7722 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2019 | 40561 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 2015 | 6773 | 0.010 |
Why?
|
| United States | 1 | 2022 | 69872 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 11524 | 0.010 |
Why?
|
| Mutation | 1 | 2019 | 29786 | 0.010 |
Why?
|
| Animals | 2 | 2015 | 168757 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 56430 | 0.010 |
Why?
|
| Adolescent | 1 | 2017 | 85781 | 0.010 |
Why?
|
| Mice | 1 | 2015 | 81183 | 0.000 |
Why?
|
Concepts
(103)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(34)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_